A Paracoccidioides brasiliensis glycan shares serologic and functional properties with cryptococcal glucuronoxylomannan  by Albuquerque, Priscila C. et al.
Fungal Genetics and Biology 49 (2012) 943–954Contents lists available at SciVerse ScienceDirect
Fungal Genetics and Biology
journal homepage: www.elsevier .com/locate /yfgbiA Paracoccidioides brasiliensis glycan shares serologic and functional properties
with cryptococcal glucuronoxylomannan
Priscila C. Albuquerque a, Radames J.B. Cordero b, Fernanda L. Fonseca a, Roberta Peres da Silva c,
Caroline L. Ramos a, Kildare R. Miranda d, Arturo Casadevall b,e, Rosana Puccia c, Joshua D. Nosanchuk b,e,
Leonardo Nimrichter a, Allan J. Guimaraes a, Marcio L. Rodrigues a,f,⇑
a Instituto de Microbiologia Professor Paulo de Góes, Universidade Federal do Rio de Janeiro, Rio de Janeiro 21941-902, Brazil
bDepartment of Microbiology and Immunology, Albert Einstein College of Medicine, 1300 Morris Park Ave., Bronx, NY 10461, USA
cDisciplina de Biologia Celular, Universidade Federal de São Paulo, São Paulo, SP 04023-062, Brazil
d Laboratorio de Ultraestrutura Celular Hertha Meyer, Instituto de Bioﬁsica Carlos Chagas Filho, Universidade Federal do Rio de Janeiro, Rio de Janeiro 21941-903, Brazil
eDivision of Infectious Diseases of The Department of Medicine, Albert Einstein College of Medicine, 1300 Morris Park Ave., Bronx, NY 10461, USA
f Fundação Oswaldo Cruz (Fiocruz), Centro de Desenvolvimento Tecnológico em Saúde (CDTS), Rio de Janeiro, Brazil
a r t i c l e i n f o a b s t r a c tArticle history:
Received 31 May 2012
Accepted 5 September 2012
Available online 23 September 2012
Keywords:
Paracoccidioides brasiliensis
Polysaccharide
Cryptococcus neoformans
Glucuronoxylomannan1087-1845  2012 Elsevier Inc.
http://dx.doi.org/10.1016/j.fgb.2012.09.002
⇑ Corresponding author at: Centro de Desenvolvim
(CDTS), Fiocruz. Av. Brasil 4.365, Casa Amarela, Ma
Janeiro, Brazil.
E-mail addresses:marciolr@cdts.ﬁocruz.br,marcio@
Open access under the ElThe cell wall of the yeast form of the dimorphic fungus Paracoccidioides brasiliensis is enriched with a1,3-
glucans. In Cryptococcus neoformans, a1,3-glucans interact with glucuronoxylomannan (GXM), a hetero-
polysaccharide that is essential for fungal virulence. In this study, we investigated the occurrence of P.
brasiliensis glycans sharing properties with cryptococcal GXM. Protein database searches in P. brasiliensis
revealed the presence of sequences homologous to those coding for enzymes involved in the synthesis of
GXM and capsular architecture in C. neoformans. In addition, monoclonal antibodies (mAbs) raised to
cryptococcal GXM bound to P. brasiliensis cells. Using protocols that were previously established for
extraction and analysis of C. neoformans GXM, we recovered a P. brasiliensis glycan fraction composed
of mannose and galactose, in addition to small amounts of glucose, xylose and rhamnose. In comparison
with the C. neoformans GXM, the P. brasiliensis glycan fraction components had smaller molecular dimen-
sions. The P. brasiliensis components, nevertheless, reacted with different GXM-binding mAbs. Extracel-
lular vesicle fractions of P. brasiliensis also reacted with a GXM-binding mAb, suggesting that the
polysaccharide-like molecule is exported to the extracellular space in secretory vesicles. An acapsular
mutant of C. neoformans incorporated molecules from the P. brasiliensis extract onto the cell wall, result-
ing in the formation of surface networks that resembled the cryptococcal capsule. Coating the C. neofor-
mans acapsular mutant with the P. brasiliensis glycan fraction resulted in protection against phagocytosis
by murine macrophages. These results suggest that P. brasiliensis and C. neoformans share metabolic path-
ways required for the synthesis of similar polysaccharides and that P. brasiliensis yeast cell walls have
molecules that mimic certain aspects of C. neoformans GXM. These ﬁndings are important because they
provide additional evidence for the sharing of antigenically similar components across phylogenetically
distant fungal species. Since GXM has been shown to be important for the pathogenesis of C. neoformans
and to elicit protective antibodies, the ﬁnding of similar molecules in P. brasiliensis raises the possibility
that these glycans play similar functions in paracoccidiomycosis.
 2012 Elsevier Inc. Open access under the Elsevier OA license.1. Introduction
Paracoccidioidomycosis (PCM) is the most prevalent mycosis in
Latin America (Queiroz-Telles and Escuissato, 2011). The impor-
tance of PCM, however, has been long underestimated, probably
because of the geographic distribution of its etiologic agent, Para-ento Tecnológico em Saúde
nguinhos, 21040-360 Rio de
micro.ufrj.br (M.L. Rodrigues).
sevier OA license.coccidioides brasiliensis (Teles and Martins, 2011), which limits it
to South America. In Brazil, about 50% of the deaths caused by sys-
temic mycoses between 1996 and 2006 were due to P. brasiliensis
(Prado et al., 2009). Although there have been advances in methods
of diagnosis and disease prevention, there is no consensus on the
best diagnostic and preventative approaches (reviewed in Teles
and Martins (2011)). Moreover, treatment of PCM requires months
to years of antimicrobial therapy and relapses are common (More-
jon et al., 2009).
Polysaccharides inﬂuence physiology and pathogenesis of fun-
gal species through multiple mechanisms. In fungi, these mole-
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cells, modulation of immunological responses, and virulence (re-
viewed in Fukazawa et al. (1995); Pirofski (2001); Rodrigues
et al. (2011a); San-Blas et al. (2000); Taylor and Roberts (2005);
Zaragoza et al. (2009)). Because of their structural and functional
particularities, fungal polysaccharides are often utilized in diag-
nostic tests, including therapeutic monitoring, in mycoses patients
(Fukazawa et al., 1995; Lopes et al., 2011). Furthermore, fungal
polysaccharides have been shown to elicit protective antibody re-
sponses when incorporated into conjugate vaccines (Torosantucci
et al., 2005). However, the current literature clearly indicates that
many aspects related to structure and functions of polysaccharides
remain unknown (Rodrigues et al., 2011a).
Glucuronoxylomannan (GXM) is a heteropolysaccharide pro-
duced by fungal pathogens belonging to the Cryptococcus and Tri-
chosporon genera (Fonseca et al., 2009a; Zaragoza et al., 2009).
This a1,3-mannan with b-xylosyl and -glucuronyl substitutions is
an active immunomodulator that is essential to the pathogenesis
of C. neoformans and C. gattii, the causative agents of human cryp-
tococcosis (Zaragoza et al., 2009). Antibodies to GXM have been
shown to alter the course of experimental animal cryptococcosis
to the beneﬁt of the host (Feldmesser and Casadevall, 1998; Pirof-
ski, 2001), supporting the notion that GXM-binding antibodies
might be useful in preventing and treating human cryptococcosis
(Larsen et al., 2005). In addition, mimetic peptides sharing immu-
nological properties with GXM are protective in animal models of
vaccination (Pirofski, 2001). In this context, GXM represents an
attractive target for antifungals and vaccine design in the Crypto-
coccus and Trichosporon models. Currently, it is not known if other
pathogens can synthesize GXM-like molecules.
In C. neoformans and C. gattii, GXM is both cell-wall associated
and released to the extracellular space (Zaragoza et al., 2009).
GXM association to the cell wall in C. neoformans requires a1,3-
glucans (Reese and Doering, 2003; Reese et al., 2007). In fact, a C.
neoformans mutant lacking expression of the gene coding for
a1,3-glucan synthase displayed an acapsular phenotype despite
ongoing synthesis of capsular components (Reese and Doering,
2003). Disruption of the a1,3-glucan synthase gene also resulted
in increased sensitivity to temperature and in reduced levels of cell
division (Reese et al., 2007). Loss of a1,3-glucan was accompanied
by a compensatory increase in chitin/chitosan and a redistribution
of b glucan between cell wall fractions (Reese et al., 2007). These
observations clearly indicated that metabolism and cellular distri-
bution of polysaccharides are integrated and required for fungal
virulence. They also established a consistent connection between
glucan synthesis and GXM anchoring to the cell wall in C. neofor-
mans and, possibly, other fungi. In fact, capsular material from C.
neoformans binds to isolates of Histoplasma capsulatum containing
cell wall-associated a1,3-glucan, but not to H. capsulatum strains
lacking synthesis of this glucan (Reese and Doering, 2003).
Synthesis of a1,3-glucan by P. brasiliensis yeast cells is associ-
ated with fungal virulence (San-Blas and San-Blas, 1977; San-
Blas and Vernet, 1977). The presence of a polysaccharide with
the ability to anchor C. neoformans GXM in the parasitic forms
of P. brasiliensis led us to investigate whether these two patho-
genic species would share metabolic events related to the syn-
thesis of GXM. By combining serologic, chromatographic, and
microscopic approaches with a phagocytosis model of polysac-
charide-coated yeast cells, we observed that P. brasiliensis pro-
duces glycans that share structural, serologic and functional
properties with cryptococcal GXM. These results suggest that
some of the pathogenic mechanisms used by C. neoformans to
damage the host and/or avoid host responses may be similar
to those used by P. brasiliensis, and these observations open
new avenues for the identiﬁcation of therapeutic and diagnostic
targets in P. brasiliensis.2. Materials and methods
2.1. Fungal strains and growth conditions
The P. brasiliensis strain used in this study was the reference
strain Pb 18, provided by Dr. Rosely Zancope-Oliveira (Fiocruz,
Rio de Janeiro, Brazil). Yeast forms were cultivated in Fava Netto’s
medium (proteose peptone 3 g, peptone 10 g, beef extract 5 g, so-
dium chloride 5 g, yeast extract 5 g, dextrose 40 g, H2O 1 L)
(Fava-Netto, 1955) for 7 days at 37 C. A number of experiments
in this study included C. neoformans cells; strains used were the
standard serotype A isolate H99 and the acapsular mutant Cap67.
C. neoformans yeast were cultivated in a minimal medium com-
posed of 15 mM glucose, 10 mM MgSO4, 29.4 mM KH2PO4,
13 mM glycine and 3 lM thiamine-HCl (pH 5.5) for 2 days at
30 C, with shaking. P. brasiliensis and C. neoformans yeast cells
were obtained by centrifugation, washed in phosphate-buffered
saline (PBS) and counted in a Neubauer chamber. Some of the sero-
logic tests developed in this study required mycelial cells of P. bra-
siliensis (Pb 18), in addition to control systems using Candida
albicans (strain IBEX 11, Tavares et al., 2008) and Saccharomyces
cerevisiae (strain BY4741, provided by Dr. Marcos Pereira, Federal
University of Rio de Janeiro) yeast cells. P. brasiliensismycelia were
cultivated in Sabouraud broth with shaking for 7 days at 25 C. Fil-
amentous cells were collected and washed by ﬁltration as previ-
ously described (Soares et al., 1993). S. cerevisiae and C. albicans
yeast cells were cultivated for 48 h in Sabouraud broth with shak-
ing, followed by centrifugation and washing.
2.2. Protein database searches
Numerous genes related to GXM synthesis and export have
been characterized in the last two decades (Chang et al., 1997,
1996, 1995; Chang and Kwon-Chung, 1998, 1999; Cottrell et al.,
2007; Garcia-Rivera et al., 2004; Janbon et al., 2001; Klutts and
Doering, 2008; Kmetzsch et al., 2011; Kumar et al., 2011; Moyrand
et al., 2002; Panepinto et al., 2009; Sommer et al., 2003; Yoneda
and Doering, 2006). Sequences of the proteins related to these pro-
cesses were obtained from the Uniprot database (www.uni-
prot.org) and used in Blast searches (protein query/protein
database) to ﬁnd homologous in the P. brasiliensis proteomic data-
base. Hits showing the highest scores of similarity were selected
and are presented in Table 1.
2.3. Preparation of C. neoformans GXM
C. neoformans GXM was isolated as previously described by ﬁl-
tration of fungal supernatants in Amicon (Millipore, Danvers, MA)
ultraﬁltration cells (cutoff 100 kDa) (Nimrichter et al., 2007). After
concentration of the supernatant, the viscous GXM-containing ﬁlm
layer was collected with a cell scraper and was transferred to plas-
tic tubes for carbohydrate quantiﬁcation. Carbohydrate contents
were determined as per Dubois et al. (1951).
2.4. Preparation of fungal glycan fractions
Cellular fractions were used to search for P. brasiliensis glycans
using a protocol that was previously established for extraction of
C. neoformans GXM (Maxson et al., 2007b). P. brasiliensis yeast cells
(2  109) were suspended in DMSO (15 ml) and incubated for
15 min with shaking at room temperature. Supernatants contain-
ing released glycans were collected by centrifugation and the pellet
was again suspended in 15 ml DMSO for a second extraction under
the same conditions. Supernatants were combined and extensively
dialyzed against water for subsequent lyophilization and dry
Table 1
Proteins required for capsule formation, GXM synthesis and polysaccharide export in C. neoformans and their P. brasiliensis Pb18 homologs.
Gene (references) C. neoformans protein (UniProt
accession number)
P. brasiliensis protein (UniProt
accession number)
Identity E-value Protein family
Cellular events: capsule formation and/or polysaccharide synthesis
CAP10 (Chang and Kwon-Chung,
1999)
Capsule-associated protein 10
(Q9HGG9)
Conserved hypothetical protein
(C1G0T3)
33% 7  1016 Glycosyltransferase
CAP64 (Chang et al., 1997, 1996) Capsular-associated protein 64
(Q9HGG3)
Not found – – –
CAP60 (Chang and Kwon-Chung,
1998)
Capsular-associated protein 60
(Q9HGG6)
Not found – – –
GMT2 (Cottrell et al., 2007) GDP-mannose transporter
(P0CS04)
GDP-mannose transporter
(C1GF36)
57% 1  10104 Nucleotide-activated
monosaccharide transporter
GMT1 (Cottrell et al., 2007) GDP-mannose transporter
(P0CS02)
GDP-mannose transporter
(C1GF36)
59% 1  10104 Nucleotide-activated
monosaccharide transporter
CXT1 (Klutts and Doering, 2008) Xylosyltransferase (Q5K8R6) Conserved hypothetical protein
(C1G0T3)
28% 3  1045 Glycosyltransferase
CMT1 (Sommer et al., 2003) a1,3-Mannosyltransferase
(A5D938)
Conserved hypothetical protein
(C1GGS1)
24% 7  106 Glycosyltransferase
CAS1 (Janbon et al., 2001; Moyrand
et al., 2002)
O-acetyltransferase (Q8X226) Not found – – –
Cellular event: GXM export
SAV1 (Yoneda and Doering, 2009) Rab/GTPase (E2IFI6) GTP-binding protein (C1G092) 73% 2  1077 Ras-like proteins
SEC6 (Panepinto et al., 2009) Vesicle fusion protein (Q5K9B3) Conserved hypothetical protein
(C1G3V8)
26% 3  1078 Exocyst complex component
CAP59 (Chang et al., 1995; Garcia-
Rivera et al., 2004)
Capsular-associated protein 59
(O93823)
Conserved hypothetical protein
(C1GGS1)
29% 8  105 Glycosyltransferase
GRASP (Kmetzsch et al., 2011) Golgi reassembly and stacking
(A6ZZA4)
Conserved hypothetical protein
(C1G8Y3)
26% 5  1020 GRASP55/65 PDZ-like domain
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arations obtained from C. albicans and S. cerevisiae. Glycan fractions
from P. brasiliensismycelial cells (2.5 g, wet weight) were similarly
prepared for serologic tests. For light scattering analysis, the same
protocol was used to extract GXM from C. neoformans cells.
2.5. Alkali treatment of fungal glycans
Removal of O-acetyl groups of GXM and similar groups poten-
tially present in the P. brasiliensis molecule was performed by dis-
solving 5 mg of the glycans in 1 ml of H2O adjusted to pH 11.25
with NH4OH. The resulting solution was stirred for 24 h at 23 C
and dialyzed against water.
2.6. Fluorescence microscopy
The different components tested in this study included P. brasil-
iensis yeast forms, in addition to glycan-coated Cap67 cells. Yeast
cells (106) were suspended in 4% paraformaldehyde cacodylate
buffer (0.1 M, pH 7.2) and incubated for 30 min at room tempera-
ture. Fixed yeast cells were washed twice in PBS and incubated in
1% bovine serum albumin in PBS (PBS-BSA) for 1 h. For glycan
staining, blocked cells were incubated with different monoclonal
antibodies (mAbs) to cryptococcal GXM. MAbs to GXM that were
available at our laboratory were generated in previous studies
and included IgMs (mAbs 13F1 and 2D10) (Cleare and Casadevall,
1998; Garcia-Rivera et al., 2004) and IgG1 (mAb 18B7) (Casadevall
et al., 1998). These mAbs differ in ﬁne speciﬁcity and protective
efﬁcacy. MAb 13F1 is not protective and produces punctate immu-
noﬂuorescence (Mukherjee et al., 1995, 1992). MAb 2D10 (IgM) re-
acts with cell wall and capsular epitopes of C. neoformans and is
protective in a murine model of cryptococcosis (Garcia-Rivera
et al., 2004). MAb 18B7 is a protective IgG1 that has been tested
as a therapeutic tool in animals and humans (Casadevall et al.,
1998; Larsen et al., 2005). This antibody reacts with all GXM sero-
types. After incubation in primary antibodies, yeast cells were
washed and then incubated with Alexa Fluor 488-labeled goat
anti-mouse (IgG or IgM) antibodies (Invitrogen). In someconditions, yeast cells were incubated with the mAbs in the pres-
ence of the P. brasiliensis glycan fraction (1–100 lg/ml). After
washing, yeast cells were applied to slides and observed using an
Axioplan 2 ﬂuorescence microscope (Zeiss, Germany). Images were
acquired using a Color View SX digital camera and were processed
with the analySIS software system (Soft Imaging System) prior to
processing with ImageJ software (provided by NIH, http://rsb.info.-
nih.gov/ij/). For controls, mAbs were replaced by irrelevant iso-
type-matched antibodies. Yeast grown in minimal medium alone
were used as a control for the experiments examining glycan-
coated acapsular cells. Exposure times were similar for all
conditions.2.7. Serologic reactivity of fungal glycans with mAbs to GXM
The reactivity of the P. brasiliensis glycan fractions with mAbs to
cryptococcal GXM was determined by enzyme-linked immunosor-
bent assays (ELISAs), using modiﬁcations of a previously described
protocol for GXM detection (Casadevall et al., 1992). Polystyrene
96-well plates were coated with 0.5 lg/ml solutions of the P. bra-
siliensis glycan fraction and incubated for 1 h at 37 C. Alterna-
tively, the plates were coated with DMSO extracts from S.
cerevisiae or C. albicans (negative controls) at the same concentra-
tion. After washing to remove unbound polysaccharide, the plates
were blocked with 1% bovine serum albumin, followed by addition
of the mAbs to GXM. After incubation for 1 h at 37 C, the plates
were washed ﬁve times with tris-buffered saline (TBS) supple-
mented with 0.1% Tween 20, followed by incubation with alkaline
phosphatase-conjugated goat anti-mouse secondary antibodies for
1 h. Color reaction developed after the addition of p-nitrophenyl
phosphate disodium hexahydrate and the absorbance was mea-
sured at 405 nm with a microplate reader (Biotek EL808 reader).
Primary antibodies and alkaline phosphatase-conjugated antibod-
ies corresponded to 1 lg/ml. A comparison between the serologic
reactivity of the native glycan fraction obtained from P. brasiliensis
yeast cells with alkali-treated (de-O-acetylated) and mycelial gly-
cans was also included in antibody-binding assays. Since these
tests involved quantitative comparisons between chemically
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rene plates, glycan antigens (0.03–1 lg in 5 ll PBS) in these assays
were loaded onto nitrocellulose membranes for dot blot analysis
(Nimrichter et al., 2007). The membranes were allowed to dry for
1 h at 37 C and then were blocked with PBS containing 1% bovine
serum albumin. Blocked membranes were incubated with mAb
18B7 at 1 lg/ml. After being washed extensively, membranes were
sequentially incubated with alkaline phosphatase-conjugated goat
anti-mouse IgG and p-nitrophenyl phosphate solutions. Reactions
were quantiﬁed by the transfer of the soluble, colored products
to the wells of 96-well plates and absorbance reading at 405 nm
as described above.
2.8. Monosaccharide analysis
Monosaccharide components of the P. brasiliensis glycan frac-
tion were determined by gas chromatography/mass spectrometry
(GC/MS) analysis of the per-O-trimethylsilyl (TMS) derivatized
monosaccharides. The dry sample (0.3 mg) was submitted to
methanolysis in methanol/1 M HCl at 80 C (18–22 h) for prepara-
tion of methyl glycosides. The sample was then treated with Tri-Sil
(Pierce) at 80 C (0.5 h) for per-O-trimethylsilylation. GC/MS anal-
ysis of the per-O-TMS derivatives was performed on an HP 5890
gas chromatograph interfaced to a 5970 MSD mass spectrometer,
using a Supelco DB-1 fused silica capillary column (30 m 
0.25 mm ID). Carbohydrate standards included arabinose, rham-
nose, fucose, xylose, glucuronic acid, galacturonic acid, mannose,
galactose, glucose, mannitol, dulcitol and sorbitol.
2.9. Effective diameter determination of glycan fractions
Effective diameter and size distribution of molecules in GXM
preparations were measured by Quasi elastic light scattering in a
90Plus/BI-MAS Multi Angle Particle Sizing analyzer (Brookhaven
Instruments Corp., Holtsville, NY), according with the method de-
scribed by Frases and colleagues (Frases et al., 2009). Multimodal
size distribution analysis of polysaccharides was calculated from
the values of intensity weighted sizes obtained from the non-neg-
atively constrained least squared (NNLS) algorithm for further pro-
cessing with GraphPad Prism software (version 5.0).
2.10. Glycan detection in extracellular vesicles
Vesicles were isolated from P. brasiliensis culture supernatants
by sequential centrifugation as recently described (Vallejo et al.,
2011, 2012a, 2012b). Vesicle pellets were lyophilized and sus-
pended in 100 ll of absolute methanol, resulting in the immediate
formation of a precipitate. The suspension was then supplemented
with 900 ll of chloroform and the organic fractionwas recovered by
centrifugation. The residual material that was not soluble in the
chloroform–methanol mixture was then dried under a nitrogen
stream, suspended in PBS, and assayed for the presence of GXM-
related glycans by ELISA with mAb 18B7. The organic phase, con-
taining lipids, was recovered for analysis by high-performance
thin-layer chromatography (HPTLC) aiming at the detection of ster-
ols, which were previously characterized as extracellular vesicle li-
pid markers in fungi (Oliveira et al., 2010b; Rodrigues et al., 2007;
Vallejo et al., 2012a). Sterol analysis by HPTLCwas performed as de-
scribed (Oliveira et al., 2010a, 2010b, 2009; Rodrigues et al., 2007).
2.11. Coating acapsular C. neoformans cells with fungal glycans
Acapsular C. neoformans cells (strain Cap67, 106 cells) were sus-
pended in solutions of puriﬁed GXM or of the P. brasiliensis glycan
fraction (100 ll, 10 lg/ml) and incubated for 18 h at 25 C, fol-
lowed by extensive washing with PBS. Control systems consisted
of Cap67 cells incubated in minimal medium.2.12. Scanning electron microscopy (SEM)
Acapsular cells of C. neoformans or the glycan-coated mutant
were washed in PBS and ﬁxed in 0.1 M sodium cacodylate buffer
containing 2.5% glutaraldehyde for 1 h and prepared for SEM as re-
cently described (Ramos et al., 2012). Brieﬂy, the cells were
washed in a buffer containing 0.1 M sodium cacodylate, 0.2 M su-
crose and 2 mM MgCl2. The samples were ﬁxed on coverslips
coated with poly-L-lysine for 20 min. Preparations were then seri-
ally dehydrated in alcohol (30%, 50%, 70% and 100% for 5 min and
95% and 100% for 10 min), and submitted to critical point drying
and metallization. The cells were observed in a scanning electron
microscope (JEOL JSM-5310).2.13. Phagocytosis
The murine macrophage cell line RAW 264.7 (American Type
Culture Collection, Rockville, MD) was grown to conﬂuence in
25 cm2 culture ﬂasks containing Dulbecco’s modiﬁed Eagle’s med-
ium (DMEM) supplemented with 10% fetal bovine serum (FBS), at
37 C in a 5% CO2 atmosphere. For interaction with glycan coated-
or uncoated yeast cells, the macrophages were cultivated in 24-
well plates, in the same conditions described above. The cell wall
of fungal cells was stained with 0.5 mg/ml ﬂuorescein isothiocya-
nate (FITC, Sigma) in PBS (25 C) for 10 min. FITC reacts with amino
groups on surface proteins, generating ﬂuorescent yeast cells. This
approach has been consistently used for the quantitative analysis
of phagocytosis of yeast cells by ﬂow cytometry (Barbosa et al.,
2006; Nogueira et al., 2010). FITC-labeling does not impact yeast
viability. Yeast suspensions were prepared in DMEM, to generate
a ratio of 10 yeasts per macrophage-like cell. Interactions between
fungal and host cells occurred at 37 C in a 5% CO2 atmosphere for
18 h. After removal of non-adherent fungi by washing, yeast-host
cell complexes were treated for 10 min at 25 C with trypan blue
(200 lg/ml) and washed. Trypan blue is a quenching agent of
FITC-derived ﬂuorescence and is useful to discriminate between
surface-associated and intracellular yeast cells, because it is not
capable of penetrating the intracellular compartment of viable
cells. Thus this dye quenches the ﬂuorescence of non-internalized
cells. Cells were gently removed from the plastic surface with a cell
scrapper. The cells were analyzed by ﬂow cytometry on a FACSCal-
ibur (BD Biosciences, San Jose, CA) ﬂow cytometer. Data were pro-
cessed with Cyﬂogic software (www.cyﬂogic.com). The index of
infection was determined as the percentage of ﬂuorescent host
cells. Control preparations were developed as described above
using uninfected cells and infecting with non-stained yeast. Each
experiment was repeated twice.3. Results
3.1. The P. brasiliensis genome contains homologous genes to those
involved in GXM synthesis
We ﬁrst sought to evaluate whether P. brasiliensis and C. neofor-
manswould share protein sequences related to the metabolic steps
involved in GXM synthesis, capsule formation and polysaccharide
export. We ﬁrst selected proteins coded by genes that directly af-
fected capsular structures in C. neoformans (Chang et al., 1997,
1996, 1995; Chang and Kwon-Chung, 1998, 1999; Cottrell et al.,
2007; Janbon et al., 2001; Klutts and Doering, 2008; Kmetzsch
et al., 2011; Moyrand et al., 2002; Panepinto et al., 2009; Sommer
et al., 2003; Yoneda and Doering, 2009) and classiﬁed them as in-
volved in (i) capsule formation and GXM synthesis and (ii) GXM
export (Table 1), based on the literature on the generation of cap-
sule-deﬁcient mutants. Nine of the 12 candidates we selected had
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coded by two genes required for capsule formation in C. neofor-
mans (CAP64 and CAP60) and by one gene required for GXM O-acet-
ylation (CAS1) produced negative results. P. brasiliensis had
homologs for all proteins required for polysaccharide export in C.
neoformans and also for building the non-acetylated GXM back-
bone. We therefore hypothesized that P. brasiliensis may have the
metabolic apparatus required for the synthesis of polysaccharides
with antigenic similarity to the C. neoformans GXM, but not neces-
sarily for the formation of a large, physical capsule.
3.2. P. brasiliensis produces glycans that share serologic and structural
properties with cryptococcal GXM
The hypothesis that P. brasiliensis can synthesize molecules with
serologic similarity with cryptococcal GXM was ﬁrst tested by
immunoﬂuorescence using mAbs 18B7, 2D10 and 13F1 (Fig. 1A).
All antibodies reacted with the surface of yeast cells in a cell
wall-associated punctate pattern. In addition, the GXM-binding
mAbs recognized extracellular structures that accumulated in the
budding neck and in intercellular spaces formed by dividing cells.
Fluorescent reactions were not observed when primary antibodies
were replaced with isotype-matched irrelevant antibodies. To test
the speciﬁcity of the reactions between P. brasiliensis molecules
and the GXM-binding antibodies, we selected mAbs 18B7 and
2D10 for immunoﬂuorescence reactivity in the presence of varying
concentrations of the Paracoccidioides glycan obtained by DMSO
extraction (Maxson et al., 2007a, 2007b). Fluorescent reactions
were efﬁciently inhibited when glycan fractions were used at 10
and 100 lg/ml (Fig. 1B). We estimated the efﬁcacy of the glycan-
mediated inhibition of antibody binding by counting the number
of surface-associated ﬂuorescence spots in at least 100 yeast cells.
According to this calculation, the P. brasiliensis glycan fraction
inhibited mAb binding by approximately 70% and 90% at 10 and
100 lg/ml, respectively. This inhibitory proﬁle was similar for both
mAbs. Altogether, these results suggested the existence of surface
structures in P. brasiliensis that share serologic properties with
cryptococcal GXM.
To exclude the possibility that the results observed in Fig. 1
originated from unspeciﬁc reactivity of GXM-binding mAbs withFig. 1. A surface glycan of P. brasiliensis (Pb18) yeast cells shares serologic properties with
monoclonal antibodies (mAbs 18B7, 2D10 and 13F1) generated to C. neoformans GXM
replaced with isotype matched irrelevant antibodies, as illustrated for IgG1 in the ‘None’ p
antibodies (not shown). P. brasiliensis cells yeast cells are shown under differential interf
panel) demonstrates that the molecules recognized by the anti-GXM antibodies are exter
yeast cells incubated with mAbs 18B7 and 2D10 in the presence of varying concentra
efﬁciently inhibited recognition of yeast cells by the GXM antibodies. P. brasiliensis cells ye
bar, 20 lm.surface P. brasiliensis structures, we extended the serologic ap-
proach for detection of GXM-related molecules to another model
of antigen–antibody reactivity. Glycan fractions extracted from P.
brasiliensis yeast cells were used in ELISA with different mAbs
raised to cryptococcal GXM. All mAbs showed dose-dependent
serologic reactivity with the P. brasiliensis extract with variable
afﬁnities (Fig. 2A), with the IgG1 18B7 having the best binding.
The GXM-binding antibodies showed negligible reactivity with
DMSO extracts obtained from either C. albicans or S. cerevisiae yeast
cells.
O-acetylation is a serologic marker of cryptococcal GXM (Kozel
et al., 2003), which led us to evaluate whether the presence of this
group would affect antibody recognition of the fungal glycans. As
expected, GXM de-O-acetylation caused a marked reduction in its
reactivity with mAb 18B7 (Fig. 2B). The P. brasiliensis glycan frac-
tion, however, was not affected by alkali treatment, which is in
agreement with the lack of mannosyl O-acetyltransferases in this
fungus (Table 1). We ﬁnally tested whether the saprophytic form
of P. brasiliensis would produce similar molecules. Immunoﬂuores-
cence experiments were inconclusive due to high backgrounds
(data not shown), but serologic tests with DMSO extracts from
mycelial cells revealed that the ﬁlamentous forms of P. brasiliensis
also produce molecules that share epitopes with cryptococcal GXM
(Fig. 2C).
Crude culture supernatants of P. brasiliensis were also tested for
reactivity with GXM-binding mAbs, showing negative results (data
not shown). This observation could imply that the glycan is not re-
leased extracellularly. However, we could not rule out the possibil-
ity that the P. brasiliensis molecules sharing serologic reactivity
with GXM were present in culture supernatants at concentrations
below the detection limit of our ELISA protocol. Considering that
GXM is exported in extracellular vesicles in the C. neoformansmod-
el (Oliveira et al., 2009; Rodrigues et al., 2007), we then evaluated
whether concentrated vesicle fractions isolated from P. brasiliensis
supernatants would show reactivity with mAb 18B7, the most efﬁ-
cient antibody in serologic tests with the Paracoccidioides glycan.
The presence of vesicles in ultracentrifugation fractions was con-
ﬁrmed by the positive detection of sterols in lipid extracts
(Fig. 3A). ELISA with mAb 18B7 revealed a dose-dependent recog-
nition of the extracellular vesicle fraction (Fig. 3B), suggesting thatcryptococcal GXM. (A) Reactivity of P. brasiliensis surface components with different
is shown. Fluorescent reactions were not observed when primary antibodies were
anel. Similar results were obtained with irrelevant IgMs and TRITC-labeled anti-IgM
erential contrast (DIC) and ﬂuorescence (anti-GXM) modes. Image merging (‘merge’
nally associated with the cell wall. (B) Immunoﬂuorescence analysis of P. brasiliensis
tions of the GXM-related glycan fraction. Increasing concentrations of the glycan
ast cells are shown under DIC and ﬂuorescence (mAbs 18B7 and 2D10) modes. Scale
Fig. 2. Serologic reactivity of P. brasiliensis glycans with antibodies originally raised to cryptococcal GXM. (A) Dose-dependent serologic reactivity of a DMSO extract from P.
brasiliensis with different monoclonal antibodies raised to cryptococcal GXM (18B7, IgG; 2D10 and 13F1, IgMs) as measured by ELISA. Negative controls included similar
serologic tests with DMSO extracts obtained from S. cerevisiae or C. albicans. (B) Reactivity of fungal glycans with mAb 18B7 after de-O-acetylation by alkali treatment. De-O-
acetylation affected the recognition of cryptococcal GXM (Cn glycan) by mAb 18B7. The P. brasiliensis fraction (Pb glycan) was not affected by treatment with alkali. (C) DMSO
extracts from yeast cells and mycelia show similar proﬁles of recognition by mAb 18B7. Results in B and C are representative of three independent dot blot analyses.
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larly in secretory vesicles.
The serologic reactivity of molecules in the P. brasiliensis extract
with antibodies to C. neoformans GXM was suggestive of structural
similarities in glycans produced by both fungal species. To address
this possibility, the carbohydrate composition of the P. brasiliensis
DMSO extract was analyzed by biochemical methods. After acidicFig. 3. Analysis of P. brasiliensis extracellular vesicles. (A) Detection of sterols by
HPTLC in extracellular vesicle fractions isolated from culture supernatants. (B)
Dose-dependent recognition of P. brasiliensis vesicle (Pb vesicles) and cellular glycan
(Pb glycan) fractions by mAb 18B7.methanolysis of the sample, monosaccharide constituents were
analyzed by GC. Classic criteria were used to interpret the results
of the GC analysis allowing for the potential detection of four dif-
ferent peaks for each sugar derivative, corresponding to the a-
and b-forms of furanose and pyranose rings. In combination with
MS analysis, each peak could be precisely identiﬁed, based on the
proﬁle of fragmentation observed. Fragmentation of TMS-deriva-
tives of hexoses usually generates diagnostic peaks at m/z 217
and 214 (Kamerling et al., 1975; Vliegenthart and Kamerling,
1975). Pyranose rings give rise to a ratio (m/z 204)/(m/z 217) > 1,
whereas furanose rings show a ratio <1. Based on the principles de-
tailed above, peaks with retention times and fragmentation pro-
ﬁles corresponding to mannopyranose (63.3%; relative intensity)
and anomers of galactose (30.3%; relative intensity), glucose
(5.2%; relative intensity), xylose (1%; relative intensity) and rham-
nose (0.3%; relative intensity) were identiﬁed (Fig. 4). Therefore,
the glycan nature of the P. brasiliensis DMSO extract was conﬁrmed,
suggesting the presence of polysaccharides constituted primarily
of mannosyl and galactosyl units and smaller amounts of glucose,
xylose and rhamnose.3.3. Molecular dimensions of C. neoformans and P. brasiliensis glycans
The fact that P. brasiliensis lacks a true capsule, but has the abil-
ity to synthesize molecules that are similar to cryptococcal GXM,
led us to evaluate whether the dimensions of glycans from this
fungus and C. neoformans GXM were comparable. Glycans
from both species were analyzed by dynamic light scattering.
Fig. 4. Monosaccharide composition of the polysaccharide fraction obtained from P. brasiliensis Pb18 by DMSO extraction. Methanolysis and derivatization of the components
extracted with DMSO followed by separation by gas chromatography (A) revealed the presence of different peaks (1–9) corresponding to carbohydrate units. Mass
spectrometry analysis of each of these peaks (B) resulted in the identiﬁcation of abundant mannose and galactose, as well as of trace amounts of glucose, xylose and
rhamnose. The relative molar distribution of each monosaccharide in the DMSO extract is shown in C.
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ranging from 1500 to 2500 nm, while the C. neoformans molecules
ranged from 6000 to 9000 nm (Fig. 5). This ﬁnding is consistent
with the surface morphological features of each pathogen in the
sense that larger ﬁbrils are used to form the cryptococcal capsule
(Frases et al., 2009).
3.4. Binding of P. brasiliensis glycans to the cell surface of an acapsular
mutant of C. neoformans
The Cap67 mutant of C. neoformans is believed to lack a capsule
due to the inability to export GXM but retains the ability to incor-
porate exogenously provided capsular components onto its cell
wall (Garcia-Rivera et al., 2004; Reese and Doering, 2003). Based
on this property, the ability of the P. brasiliensis glycans to interact
with surface components of C. neoformans was tested in an immu-noﬂuorescence model. Incubation of acapsular C. neoformans cells
in the presence of the P. brasiliensis glycan fraction extracted with
DMSO resulted in binding to the cryptococcal surface (Fig. 6). Gly-
can incorporation by acapsular cryptococci differed when puriﬁed
GXM or the P. brasiliensis extract were used. The use of mAbs 18B7
and 2D10 as detection probes revealed that the acapsular mutant
bound to GXM to form an annular pattern of surface coating. In
contrast, mAb 13F1 produced a punctate pattern of antibody,
which is in agreement with a previous report (Cleare and Casadev-
all, 1998). However, punctate binding occurred with all of the
mAbs when incubated with Cap67 cells coated with the P. brasili-
ensis glycan fraction. These results indicate that, although crypto-
coccal cell wall components interact with polysaccharide
fractions obtained from both C. neoformans and P. brasiliensis, this
process varies depending on what glycan is used, possibly suggest-
ing structural differences.
Fig. 5. Size distribution of glycan fractions obtained after DMSO extraction of P.
brasiliensis Pb18 (A) and encapsulated C. neoformans H99 (B) cells.
Fig. 6. Incorporation of P. brasiliensis Pb18 (Pb) molecules by an acapsular mutant
(Cap67) of C. neoformans. Cap67 cells were treated with the Pb extract or with GXM
puriﬁed from C. neoformans H99 cultures followed by incubation with mAbs raised
to GXM. Positive reactions were observed for all antibodies, but the pattern of
reactivity depended on which polysaccharide fraction was used to coat Cap67 cells.
Scale bar, 20 lm.
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sis material was found to be tightly associated to the cell wall ofCap67 cells (Fig. 6). However, different patterns of interaction of
the P. brasiliensis glycans with acapsular cryptococci were occa-
sionally observed. In these rare cases, DIC images suggested the
formation of extracellular aggregates that were not closely at-
tached to the cell wall of the acapsular C. neoformans mutant
(Fig. 7). Analysis of these cells by immunoﬂuorescence with mAb
18B7 revealed the existence of surface structures that resemble a
capsular network, which was conﬁrmed by SEM. Although most
of the cells did not contain these surface structures, we found that
approximately 5% of the cells formed surface networks that resem-
bled fungal capsules. We therefore concluded that the P. brasiliensis
glycan is recognized by components of the cryptococcal cell wall
with possible formation of glycan networks that may be related
to fungal capsules.3.5. Binding to P. brasiliensis glycans reduces the efﬁcacy of association
of the acapsular mutant of C. neoformans with host phagocytes
Based on the results presented in Figs. 6 and 7, we asked
whether coating Cap67 cells with the P. brasiliensis glycan fraction
would affect the interaction of the mutant with macrophages, since
protection against phagocytosis is one of the primary functions of
cryptococcal GXM. We then compared the ability of uncoated
Cap67 cells to interact with phagocytic cells relative to that ob-
served for acapsular cells coated with the P. brasiliensis glycan frac-
tion. As a control, we used Cap67 cells coated with C. neoformans
H99 GXM. As expected, GXM-coated Cap67 cells were about 40%
less efﬁcient in their interactions with phagocytic cells relative to
the uncoated acapsular cells (Fig. 8A). Coating of the mutant with
the P. brasiliensis glycan resulted in 70% reduction in the ability
of the C. neoformans mutant to associate with RAW macrophages,
in comparison with uncoated yeast cells (Fig. 8B). Therefore, in
quantitative terms, the P. brasiliensis glycan fraction was approxi-
mately 50% more effective than GXM in inhibiting the interaction
of C. neoformans with RAW phagocytes (Fig. 8C).
To compare indices of uncoated and glycan-coated Cap67 adhe-
sion to and internalization by phagocytes, infected macrophages
were treated with trypan blue after infection with C. neoformans.
Trypan blue extinguishes extracellular ﬂuorescence, which implies
that the relative ﬂuorescence reduction of the macrophages after
exposure to this dye will correspond to the percentage of yeast
cells that adhered to but were not internalized by the macro-
phages. Fluorescence intensity was reduced by about 20% after
exposure of macrophages that were infected with uncoated
Cap67 cells to trypan blue (Fig. 8D), which is in agreement with
the observation that acapsular variants of C. neoformans are efﬁ-
ciently phagocytized (Kozel and Gotschlich, 1982). When macro-
phages that were infected with GXM-coated Cap67 cells were
treated with trypan blue, a decrease in ﬂuorescence intensity in
the range of 30% was observed (Fig. 8E). In similar systems where
the acapsular mutant was coated with the P. brasiliensis glycan,
ﬂuorescence reduction corresponded to 13% (Fig. 8F). Therefore,
in all cases most of the fungal cells were internalized after incuba-
tion in the presence of host phagocytes, although the variation in
ﬂuorescence reduction ﬂuctuated in the three different systems.4. Discussion
Polysaccharides are key regulators of fungal pathogenesis. In
different fungal pathogens, neutralization of polysaccharides with
antibodies, as well as the induction of immune responses to poly-
saccharides, results in modiﬁcation of the course of infection in fa-
vor of the host (Casadevall et al., 1998; Casadevall and Pirofski,
2006; Pirofski, 2001). In this context, it seems clear that
Fig. 7. Coating of Cap67 C. neoformans cells with the P. brasiliensis Pb18 extract results in the formation of capsule-like structures. (A and B) Analysis of the C. neoformans
acapsular mutant after incubation in the absence of polysaccharide fractions (control) followed by exposure to mAb 18B7 by ﬂuorescence microscopy. No serologic reactivity
was observed. Incubation of Cap67 cells with the DMSO extract from P. brasiliensis results in the formation of extracellular aggregates (C, arrows) that resembled capsular
structures when observed by ﬂuorescence microscopy (D). Differential interferential contrast (A and C) and ﬂuorescence (B and D) modes are shown. Results shown in C–D
were conﬁrmed by scanning electron microscopy of control (E) or glycan-coated (F) Cap 67 cells. Scale bars correspond to 20 lm in panels for A–D, 1 lm in E and 2 lm in F.
Fig. 8. Coating of C. neoformans Cap67 (Cn) acapsular cells with P. brasiliensis Pb18 (Pb) molecules renders yeast cells less efﬁcient in their ability to associate with
macrophage-like cells. To measure the association of the Cap67 mutant with host cells, fungi were stained with FITC and incubated with the phagocytes, which were then
analyzed by ﬂow cytometry. (A) Comparison between the indices of association of macrophages with control Cap67 cells (no coating) or with the GXM-coated mutant. (B)
Coating of Cap67 cells with the P. brasiliensis glycan fraction caused a decrease in the index of association of the acapsular mutant with macrophages. (C) Analysis of the
efﬁcacy of coating Cap67 cells with C. neoformans GXM or with the P. brasiliensis glycan fraction to inhibit the association of yeast cells with phagocytes. To differentiate
adhered and internalized yeast cells, infected macrophages were treated with trypan blue, an extinguisher of extracellular FITC-derived ﬂuorescence (D–F). The shift of
histograms to regions of lower ﬂuorescence after exposure to trypan blue denotes the presence of extracellularly-associated yeast cells. This ﬁgure is representative of three
different experiments producing similar results.
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key strategy for the design of new therapeutics.a1,3-Glucans are found in the cell walls of several pathogenic
fungi, including C. neoformans (Reese and Doering, 2003; Reese
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ces dermatitidis (Hogan and Klein, 1994) and P. brasiliensis (San-Blas
and Vernet, 1977). In H. capsulatum, gene depletion studies have
demonstrated that the virulence of certain strain types requires
a1,3-glucan (Rappleye et al., 2004). Both RNA interference
(RNAi)-mediated reduction in the synthase for a1,3-glucan
(AGS1) and traditional allelic replacement substantially reduced
the ability of the fungus to proliferate and kill macrophages in cul-
ture and decreased lung fungal burden in a murine infection mod-
el. In P. brasiliensis, a similar relationship between virulence and
a1,3-glucan has been described, as concluded from the observation
that spontaneous loss of the polysaccharide correlated with de-
creased virulence (San-Blas and San-Blas, 1977). In C. neoformans,
the lack of a1,3-glucan synthesis correlates with an acapsular phe-
notype, which was accompanied by disorganization of the cell
wall, altered polysaccharide composition, and an avirulent pheno-
type (Reese and Doering, 2003; Reese et al., 2007). The lack of vis-
ible capsules in the strain lacking a1,3-glucan was not a
consequence of altered GXM synthesis, since cells with altered
a1,3-glucan synthesis continued to shed capsule material into
the environment (Reese and Doering, 2003). This observation led
to the conclusion that a1,3-glucan was responsible for anchoring
surface GXM. In fact, capsule material from C. neoformans efﬁ-
ciently bound only to a1,3-glucan-producing H. capsulatum strains
(Reese and Doering, 2003). These cells showed a blurred and very
intense staining with a monoclonal antibody to GXM, resembling
capsular structures (Reese and Doering, 2003). Apparently, no di-
rect staining of H. capsulatum with antibodies to GXM was per-
formed by the authors, implying that the possibility that H.
capsulatum also produces GXM-like polymers could not be ruled
out at present.
P. brasiliensis is a non-encapsulated fungal pathogen. An early
report, however, indicates the occurrence of cell wall-associated
ﬁbrilar material in this species (Carbonell, 1967; Carbonell et al.,
1970). Nevertheless, it is inaccurate to state that P. brasiliensis syn-
thesizes a true capsule. Our results, however, suggest that a P. bra-
siliensis glycan fraction shares structural, functional and serologic
properties with C. neoformans GXM. The P. brasiliensis glycan shar-
ing epitopes with cryptococcal GXMwas surface-associated, but its
detection in DMSO extracts raised additional possibilities. Consid-
ering that (i) concentrated DMSO is very efﬁcient in damaging the
plasma membrane by solubilizing lipids and (ii) C. neoformans
GXM is synthesized intracellularly and then exported to the extra-
cellular space (Rodrigues et al., 2007, 2011b), we cannot rule out
the possibility that the GXM-related components of the P. brasilien-
sis glycan are also found in intracellular compartments.
Glycans sharing serologic properties with C. neoformans GXM
were detected in both mycelia and yeast cells. Given that a1,3-glu-
can is found exclusively at the cell wall of yeast forms of P. brasil-
iensis (San-Blas and Vernet, 1977), this observation suggests that
other molecules interact with the GXM-related structures in Para-
coccidioides yeast cells, as was previously described for chitin in C.
neoformans and T. asahii (Fonseca et al., 2009a, 2009b; Ramos et al.,
2012; Rodrigues et al., 2008a). The molecular dimensions of the P.
brasiliensis glycan were smaller than those reported for C. neofor-
mans H99 GXM and similar to those from hypocapsular C. neofor-
mans (Kmetzsch et al., 2011), which is consistent with the
acapsular morphology of P. brasiliensis. Nevertheless, acapsular C.
neoformans cells were able to use the P. brasiliensis glycans to con-
struct surface structures that resembled capsular networks, indi-
cating that both species used similar polysaccharides to protect
themselves against the immune defense and environmental preda-
tors. In fact, several mechanisms of pathogenicity and immunolog-
ical escape are shared by C. neoformans and P. brasiliensis, including
pigmentation (Gomez et al., 2001; Wang et al., 1995), production
of extracellular matrix-degrading proteases (Puccia et al., 1998;Rodrigues et al., 2003), sialylation of surface glycoproteins
(Rodrigues et al., 2002; Soares et al., 1998), synthesis of immuno-
genic glycosylceramides (Bertini et al., 2007; Rodrigues et al.,
2000), ability to attach to host cells in the lung (Barbosa et al.,
2006; Gonzalez et al., 2008) and vesicular secretion of virulence
factors (Eisenman et al., 2009; Rodrigues et al., 2008b, 2007;
Vallejo et al., 2011, 2012b). Our results are indeed suggestive that
extracellular vesicles are involved in export of the currently stud-
ied P. brasiliensis glycan. In C. neoformans and P. brasiliensis, extra-
cellular vesicles have been demonstrated to be immunologically
active (Oliveira et al., 2010a; Rodrigues et al., 2008b; Vallejo
et al., 2011), which is likely inﬂuenced by the presence of GXM
and other glycans in these secretory compartments.
Our analysis of the P. brasiliensis homologs corresponding to
proteins involved in C. neoformans GXM synthesis, capsule forma-
tion and polysaccharide export was consistent with our experi-
mental ﬁndings and with the literature in the ﬁeld. For instance,
two of the three proteins involved in capsule formation in C. neo-
formans (Chang and Kwon-Chung, 1998; Chang et al., 1996) were
not found in P. brasiliensis, which is consistent with the lack of a
capsule in this pathogen and with the reduced dimensions of its
glycans that have antigenic similarities to GXM. In fact, polysac-
charide enlargement was demonstrated to be essential for capsule
growth in C. neoformans (Frases et al., 2009). On the other hand, P.
brasiliensis had homologs for the genes required for C. neoformans
GXM synthesis and export, except O-acetylation. These observa-
tions are in agreement with serologic, biochemical and microscopic
data suggesting that P. brasiliensis produces a surface glycan likely
representing a substituted mannan. The synthesis of mannans does
not necessarily translate to capsule formation, since it is well
known that, in C. neoformans, capsular assembly depends also on
the interaction of GXM with other components, including glucu-
ronoxylomannogalactan (GXMGal) (De Jesus et al., 2009). This
observation may be also be related to the fact that some of the
acapsular C. neoformans cells used the P. brasiliensis glycan fraction
to form surface networks that resembled fungal capsules. The
acapsular mutant used in this study is known to be an efﬁcient pro-
ducer of GXMGal (Vaishnav et al., 1998), which could interact with
the P. brasiliensis glycan to form capsule-like structures. Based on
our current data, it is impossible to afﬁrm that these structures
form true capsules, but the possibility that P. brasiliensis formed
extracellular aggregates that would then be incorporated onto
the cryptococcal cell surface with consequent formation of cap-
sule-like structures cannot be ruled out, considering the ability of
GXM to self-aggregate (Nimrichter et al., 2007). Another important
issue particularly related to this model is the suggestion that, de-
spite the similarities detected in our studies, P. brasiliensis and C.
neoformans glycans are likely to differ in certain structural aspects,
as concluded from the different patterns of serologic reactivity
after incorporation into the surface of acapsular cells, as well as
lack of glucuronic acid as a monosaccharide constituent and ab-
sence of O-acetylation.
The complete structure of the P. brasiliensis glycan still remains
to be elucidated. The abundance of mannose and galactose sug-
gests a galactomannan, which has been previously described in
this fungus (San-Blas and San-Blas, 1982) and characterized in de-
tail in Aspergillus species (Latge, 2009). Interestingly, preliminary
data from our laboratory shows that A. fumigatus conidia were efﬁ-
ciently labeled by mAb 18B7 (P.C. Albuquerque, E. Barreto-Bergter
and M.L. Rodrigues, unpublished). H. capsulatum glycans are also
recognized by GXM-binding antibodies (A. Guimarães, unpub-
lished) and this fungus also produces antigens that cross-react
with galactomannan (Zancope-Oliveira et al., 1994). These obser-
vations are all consistent with the notion that the P. brasiliensis
GXM-related glycan identiﬁed in this study is a galactomannan.
However, the detection of glucose, xylose and rhamnose may sug-
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of different polysaccharides in the same fraction. Improved meth-
ods for puriﬁcation of theses P. brasiliensismolecules and complete
structural elucidation are underway in our laboratory. Serologic
epitopes in the P. brasiliensis glycan also remain to be determined.
Using a set of mAbs that were not related to those used in this
study, Kozel and colleagues demonstrated that GXM de-O-acetyla-
tion affected the reactivities of ﬁve of seven anti-GXM antibodies
(Kozel et al., 2003). In addition, loss of xylosylation in C. neoformans
produced a substantive alteration in the binding behavior of one
mAb. These results demonstrated that polysaccharide O-acetyla-
tion and xylosylation are determinant for the serologic reactivity
of cryptococcal GXM and support the hypothesis that additional
epitopes exist in the P. brasiliensis glycan, considering the lack of
genes required for mannose O-acetylation, resistance to alkali
treatment and the trace amounts of xylose found in the glycan
fraction obtained from this fungus. Regardless, it seems plausible
to suggest, based on our current data, that the synthesis of GXM-
related polymers is not restricted to pathogenic Cryptococcus spe-
cies. In fact, different reports demonstrate that fungal species that
include C. liquefaciens (Araujo Gde et al., 2012) and Trichosporon
asahii (Fonseca et al., 2009a) produce GXM-like polysaccharides
that share structural, antiphagocytic and serologic properties with
the polysaccharides produced by C. neoformans and C. gattii.
Protection against phagocytosis is a principal function of cryp-
tococcal GXM (Kozel and Gotschlich, 1982). In our study, coating
acapsular C. neoformans cells with exogenous P. brasiliensis glycans
suggested that the latter molecules could also impact P. brasiliensis
yeast cell interactions with host effector cells. The C. neoformans
polysaccharide has diverse additional functions, most of them re-
lated to modulation of the immune response (Zaragoza et al.,
2009). GXM is severely deleterious to a number of host’s immuno-
logical mechanisms but, depending on structural particularities
and molecular dimensions, the polysaccharide may exert paradox-
ical functions to stimulate the host response (Fonseca et al., 2010;
Rodrigues et al., 2011a). The clear relevance of GXM for disease
progress and the uniqueness in its structure and functions make
this polysaccharide an attractive target for antifungal therapy.
The observation that, as previously described for Trichosporon spe-
cies (Fonseca et al., 2009a), molecules with properties that resem-
bled those described for cryptococcal GXM are found in non-
Cryptococcus fungal species suggest that antibodies to GXM and/
or similar tools may be therapeutic in different models of fungal
infections. Since the ability of the P. brasiliensis glycan fraction to
stimulate the immune response is still unknown, its use in vaccine
preparations could be also possible.
Our results add P. brasiliensis to the group of fungal pathogens
producing GXM-related molecules. Considering the major impact
that this polysaccharide exerts in infections caused by C. neofor-
mans, C. gattii and, possibly, Trichosporon species, the possibility
that the currently identiﬁed glycan impacts the pathogenesis of
PCM is intriguing from an evolutionary standpoint as well as rep-
resenting potential targets for diagnostics and therapeutics. Signif-
icantly, the use of mimetic peptides and passively administered
protective antibodies to prevent and treat animal and human
PCMmay represent new promising alternatives to control this fun-
gal infection.
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